Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (181-190 of 335) with videos related to

Pageof 34
Sort By:
Circulation|September 1, 2016
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy StudyCharles D Resor, Ashwin Nathan, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|August 23, 2014
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trialSammy Elmariah, Anthony J Furlan, Mark Reisman, et al.
Journal of the American Society of Hypertension : JASH|May 17, 2015
Renal denervation therapy for hypertension: pathways for moving development forwardWilliam B White, Zorina S Galis, Jeffrey Henegar, et al.
JACC. Cardiovascular Interventions|May 26, 2009
3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trialDavid R Holmes, Paul S Teirstein, Lowell Satler, et al.
The New England Journal of Medicine|March 16, 2012
Closure or medical therapy for cryptogenic stroke with patent foramen ovaleAnthony J Furlan, Mark Reisman, Joseph Massaro, et al.
Circulation. Cardiovascular Interventions|July 8, 2010
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registryJoshua M Stolker, Kevin F Kennedy, Jason B Lindsey, et al.
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT StudyKamil F Faridi, Hector Tamez, Neel M Butala, et al.
Journal of the American College of Cardiology|October 2, 2007
Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trialMarie-Claude Morice, Patrick W Serruys, Paul Barragan, et al.
The American Journal of Cardiology|November 10, 2010
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials)Pallav Garg, David M Charytan, Lena Novack, et al.
Stroke|November 6, 2010
Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovaleAnthony J Furlan, Mark Reisman, Joseph Massaro, et al.
Pageof 34

Showing results (181-190 of 335) with videos related to

Sort By:
Pageof 34
Circulation|September 1, 2016
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy StudyCharles D Resor, Ashwin Nathan, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|August 23, 2014
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trialSammy Elmariah, Anthony J Furlan, Mark Reisman, et al.
Journal of the American Society of Hypertension : JASH|May 17, 2015
Renal denervation therapy for hypertension: pathways for moving development forwardWilliam B White, Zorina S Galis, Jeffrey Henegar, et al.
JACC. Cardiovascular Interventions|May 26, 2009
3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trialDavid R Holmes, Paul S Teirstein, Lowell Satler, et al.
The New England Journal of Medicine|March 16, 2012
Closure or medical therapy for cryptogenic stroke with patent foramen ovaleAnthony J Furlan, Mark Reisman, Joseph Massaro, et al.
Circulation. Cardiovascular Interventions|July 8, 2010
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registryJoshua M Stolker, Kevin F Kennedy, Jason B Lindsey, et al.
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT StudyKamil F Faridi, Hector Tamez, Neel M Butala, et al.
Journal of the American College of Cardiology|October 2, 2007
Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trialMarie-Claude Morice, Patrick W Serruys, Paul Barragan, et al.
The American Journal of Cardiology|November 10, 2010
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials)Pallav Garg, David M Charytan, Lena Novack, et al.
Stroke|November 6, 2010
Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovaleAnthony J Furlan, Mark Reisman, Joseph Massaro, et al.
Pageof 34